#115 The G|O Briefing, October 27, 2022
Negotiating with the devil | The tale of an unofficial Swiss early private peace initiative | Give peace a chance
BIG PHARMA
Is America (finally) back in Geneva?
The WTO's 12th ministerial conference (MC12) last week afforded a provisional rescue to the institution, greeted by a global and collective sigh of relief. But the ability of the WTO to pull itself out of paralysis was not the only significant outcome of MC12. Another equally meaningful development
#102 The G|O Briefing, June 23, 2022
Fighting for better working conditions for the UN’s outside workforce - WTO: Yes it can!
When signing contracts with Big Pharma, read the fine print first
As the World Health Assembly (WHA), WHO’s governing body, is gathered this week for its Seventy-fifth annual session—for the best coverage in town, follow our colleagues at Health Policy Watch—it may come as no surprise that when discussing health, conversations about its politics are more transparent and
#99 The G|O Briefing, May 25, 2022
The World Uyghurs Congress says Michelle Bachelet has betrayed them – Big Pharma and future pandemics – Death threats against The G|O’s Jamil Chade
Subscribers Only
Big Pharma and Monopoly Capitalism: A Long-term View
Are IPRs institutions meant to foster innovative activities or conversely to se- cure appropriation and profitability? Taking stock of a long-term empirical evidence on the pharmaceutical sector in the US, we can hardly support IPRs in- tended as an innovation rewarding institution.
TRIPS Waiver proposal in Geneva mobilizes lobbyists in capitals around the world
Feeling the heat, Big Pharma has been using its financial clout to push back and engage in a frantic lobbying effort to influence governments not to join the project, documents from the US Senate and other organizations show.
How drug companies are fighting against a proposal to accept technology transfer to poor countries
This is an onsite edited excerpt of the G|O Briefing newsletter
No confinement for diplomacy when issue at stake is global access to vaccines
For the last six months or so, a draft resolution entitled “Strengthening Local Production of Medicines and Other Health Technologies to Improve Access” has been
#46 The G|O Briefing, March 24, 2021
This is an onsite, slightly edited republication of the complete G|O Briefing newsletter
Today in The Geneva Observer, thanks to a WHO draft resolution obtained by The G|O, we go behind the scenes to look at how drug companies are fighting against a proposal to accept technology transfer
#45 The G|O Briefing, March 11, 2021
Tensions between pharma and global health actors during vaccine summit - A call for gender balance at WTO - UNAIDS reacts to G|O report –